Shares of 3D Systems Corporation (NYSE: DDD) skyrocketed 28.3% to $3.22 on Tuesday, following the release of first-quarter financial results that surpassed Wall Street expectations. The surge came as the company reported revenue of $95.54 million, beating the consensus estimate of $90.6 million, and an adjusted loss per share of $0.01, which was $0.07 better than anticipated. Trading volume exploded to over 18 million shares, a dramatic increase for the small-cap additive manufacturing firm.
Healthcare Drives the Turnaround
The standout performer was the Healthcare Solutions segment, which saw revenue climb 21.3% to $50.1 million, fueled by strong sales in dental materials, printer systems, and medical parts manufacturing. This growth offset a 14.7% decline in Industrial Solutions to $45.4 million, which was impacted by divestitures and weaker jewelry demand, though aerospace and defense provided some support. The shift in business mix is significant: healthcare offers more predictable, recurring revenue compared to the lumpy printer sales that have historically weighed on results.
Adjusted EBITDA swung to a positive $2.1 million, reversing a loss in the prior-year period, as the company benefited from cost controls and a higher-margin product mix. Non-GAAP gross margin, adjusted for divestitures, improved by 600 basis points, underscoring the operational improvements. CFO Phyllis Nordstrom highlighted the "return of core revenue growth" during the earnings call.
Customer Wins and Strategic Progress
Adding to the positive sentiment, 3D Systems announced a partnership with ROE Dental Laboratory, which is deploying NextDent 300 systems across multiple facilities to triple its denture production. ROE CEO BJ Kowalski noted the equipment "exceeded our expectations," providing tangible evidence of demand from end-users. This deal reinforces the company's focus on dental applications, a key growth driver.
CEO Jeffrey Graves described the quarter as showing "green shoots," with recovery visible across dental, medical technology, and aerospace and defense. He maintained the outlook for over 20% growth in the aerospace and defense market this year, targeting approximately $35 million in revenue, and noted an 80,000-square-foot facility expansion in Littleton, Colorado, dedicated to metal component production.
Bears Remain Cautious
Despite the rally, skeptics point to ongoing challenges. The company burned $7.2 million in operating cash during the quarter, and cash and cash equivalents fell to $85.1 million from $95.6 million at year-end. Guidance for the second quarter calls for revenue between $93 million and $95 million, with adjusted EBITDA expected to remain negative, ranging from a loss of $2 million to $4 million. Additionally, management acknowledged that disclosure controls were ineffective as of March 31, with remediation of material weaknesses still underway.
The broader market context was neutral: peers like Stratasys and Proto Labs saw minimal moves, while Materialise gained nearly 3.5%. Macro factors were not a driver, as rate-cut expectations remained steady. The rally appears to be a company-specific revaluation based on the earnings beat and healthcare momentum.
For 3D Systems, the path forward hinges on whether the healthcare and aerospace segments can sustain growth and translate into consistent cash generation. Tuesday's price action suggests investors are willing to give the turnaround story a chance, but the bears will be watching the next quarter closely for signs of durability.
